ALB and liver disorder: Here, patients with stable DC were shown have an improvement in the systemic inflammation only when given high-dose albumin therapy (defined as 1.5 g/kg/wk).82Therefore, it appears that achieving serum albumin levels like that of healthy individuals (∼ 40 g/L) makes physiological sense to derive maximum benefit from albumin therapy in liver disease.